| Sno | Generic Name | Dosage Form |
|---|
| 01 |
Cetrimide Cream BP 0.5% w/w |
Each Composion: Contains:
| Cetrimide BP: | 0.5% w/w |
| Cream Base : | q. s. |
|
| 02 |
Chloroxylenol Cream 0.8% w/w |
Each Composion: Contains:
| Chloroxylenol BP : | 0.8% w/w |
| Cream Base : | q. s. |
|
| 03 |
Ciprofloxacin Cream 0.5% w/w |
Each Composion: Contains:
Ciprofloxacin Hydrochloride BP
| Eq. to Ciprofloxacin : | 0.5% w/w |
| Cream Base | q.s. |
|
| 04 |
Ciprofloxacin with Fluocinolone
& Clotrimazole Cream |
Each Composion: Contains:
Ciprofloxacin Hydrochloride BP
| Dextrose Anhydrous BP : | 20.000 g |
| Eq. to Ciprofloxacin : | 0.5% w/w |
| Fluocinolone Acetonide BP : | 0.025% w/w |
| Clotrimazole BP : | 1% w/w |
| Cream Base | q.s. |
|
| 05 |
Diclofenac Diethylamine,
Methyl Salicylate, Menthol,
Linseed Oil and Capsaicin Gel |
Each Composion: Contains:
| Diclofenac Diethylamine BP : | 1.160% w/w |
| Eq. To Diclofenac Sodium : | 1.000% w/w |
| Linseed Oil BP : | 3.000% w/w |
| Methyl Salicylate BP : | 10.000% w/w |
| Menthol BP : | 5.000% w/w |
| Capsaicin USP : | 0.025% w/w |
| Benzyl Alcohol BP (As Preservative) : | 1.000% w/w |
| Aqueous Gel Base | Q. S. |
|
| 06 |
Diclofenac with Methyl
Salicylate, Oleum Lini, Menthol
& Linseed Oil Gel (For Export) |
Each Composition: Contains:
| Diclofenac Diethylamine BP : | 1.160% w/w |
| Eq. To Diclofenac Sodium : | 1.000% w/w |
| Oleum Lini (Contains predominantly alpha
Linolenic Acid ) : | 3.000% w/w |
| Methyl Salicylate BP : | 10.000% w/w |
| Menthol BP : | 5.000% w/w |
| Benzyl Alcohol BP (As Preservative) : | 1.000% w/w |
| Aqueous Gel Base | Q. S. |
|
| 07 |
Fluocinolone Cream BP
0.025% w/w (For Export) |
Each Composition: Contains:
| Fluocinolone Acetonide BP : | 0.025 % w/w |
| Cream base | Q. S. |
|
| 08 |
Fluocinolone Ointment BP
0.01% w/w (For Export) |
Each Composition: Contains:
| Fluocinolone Acetonide BP : | 0.01 % w/w |
| Ointment base | Q. S. |
|
| 09 |
Fusidic Acid Cream BP
2% w/w (For Export) |
Each Composition: Contains:
| Fusidic Acid BP : | 2% w/w |
| Cream base | Q. S. |
|
| 10 |
Hydroquinone Cream USP
4% w/w (For Export) |
Each Composition: Contains:
| Hydroquinone USP : | 4% w/w |
| Cream base | Q. S. |
|
| 11 |
Ketoconazole Cream BP 2%
(For Export) |
Each Composition: Contains:
| Ketoconazole BP : | 2% w/w |
| Cream base | Q. S. |
|
| 12 |
Methyl Salicylate, Eucalyptus
Oil, Turpentine Oil and
Menthol Gel
(For Export) |
Each Composition: Contains:
| Methyl Salicylate BP : | 15.000% w/w |
| Eucalyptus Oil BP : | 7.000% w/w |
| Turpentine Oil BP : | 1.500% w/w |
| Menthol BP: | 6.000% w/w |
| Aqueous Gel Base | Q. S. |
|
| 13 |
Nimesulide Gel 1% w/w
(For Export) |
Each Composition: Contains:
| Nimesulide BP : | 1.000% w/w |
| Gel base | Q. S. |
|
| 14 |
Nitrofurazone Ointment USP
0.2% w/w (For Export) |
Each Composition: Contains:
| Nitrofurazone USP | 0.200% w/w |
| Chlorocresol BP | 0.100% w/w |
| Cream base | Q. S. |
|
| 15 |
Piroxicam Gel BP
(For Export) |
Each Composition: Contains:
| Piroxicam BP | 0.5% w/w |
| Gel base | Q. S. |
|
| 16 |
Povidone Iodine with
SucralfateOintment
(For Export) |
Each Composition: Contains:
| Povidone Iodine BP | 5.000% w/w |
| (Available Iodine | 0.5% w/w ) |
| Sucralfate BP | 7.000% w/w |
| Water Soluble Ointment Base | Q. S. |
|
| 17 |
Salicylic Acid Ointment BP
2% w/w (For Export) |
Each Composition: Contains:
| Salicylic Acid BP | 2% w/w |
| (Available Iodine | 0.5% w/w ) |
| Ointment Base | Q. S. |
|
| 18 |
Povidone Iodine with
Metronidazole & Aloe Ointment
(For Export) |
Each Composition: Contains:
| Povidone Iodine BP | 5.000% w/w |
| (Available Iodine | 0.5% w/w) |
| Metronidazole BP | 1.000% w/w |
| Aloe | 1.500% w/w |
| Water Soluble Ointment Base | Q. S. |
|
| 19 |
Silver Sulphadiazine with
Chlorhexidine Gluconate Cream
(For Export) |
Each Composition: Contains:
| Silver Sulphadiazine USP | 1.000% w/w |
| Chlorhexidine Gluconate Solution BP | 2.000% w/w |
| Cream Base | Q. S. |
|
| 20 |
Silver Sulphadiazine with
Chlorhexidine Hydrochloride
Cream (For Export) |
Each Composition: Contains:
| Silver Sulphadiazine BP | 1.000% w/w |
| Chlorhexidine Hydrochloride BP | 0.500% w/w |
| Cream Base | Q. S. |
|
| 21 |
Sulphur Ointment 10% w/w
(For Export) |
Each Composition: Contains:
| Sulphur Sublimed | 10.000% w/w |
| Petroleum Jelly to Make | Q. S. |
|
| 22 |
Tacrolimus Ointment 0.1%w/w
(For Export) |
Each Composition: Contains:
| Tacrolimus USP | 0.10% w/w |
| Ointment base | Q. S. |
|
| 23 |
Salicylic Acid, Benzoic Acid,
Oil Citronella & Thymol
Ointment (For Export) |
Each 15 g. Contains:
| Salicylic Acid BP | 0.950 gm |
| Benzoic Acid BP | 0.250 gm |
| Thymol BP | 0.050 gm |
| Oil Citronella | 0.100 gm |
| Petroleum Jelly Base | Q. S. |
|
| 24 |
Sucralfate, Metronidazole and
Povidone Iodine Ointment
(For Export) |
Each gm. Contains:
| Sucralfate USP | 70 mg |
| Metronidazole BP | 10 mg |
| Povidone Iodine BP | 50 mg |
| Ointment Base | Q. S. |
|
| 25 |
White Soft Paraffin and Liquid
Paraffin Cream |
Each Composition: Contains:
| White Soft Paraffin BP | 13.200% w/w |
| Liquid Paraffin BP | 10.200% w/w |
| Cream Base | Q. S. |
|
| 26 |
Zinc Cream BP 32% w/w
(For Export) |
Each Composition: Contains:
| Zinc Oxide BP | 32.000% w/w |
| Cream Base | Q. S. |
|
| 27 |
Whitfield’s Ointment
(Compound Benzoic Acid
Ointment ) BP (For Export) |
Each Composition: Contains:
| Benzoic Acid BP | 6% w/w |
| Salicylic Acid BP | 3% w/w |
| Ointment Base | Q. S. |
|
| 28 |
Silver Sulfadiazine Cream USP
1%w/w (For Export) |
Each Composition: Contains:
| Silver Sulfadiazine USP | 1% w/w |
| Methyl Paraben BP (Preservatives) | 0.165%w/w |
| Propyl Paraben BP (Preservatives) | 0.077%w/w |
| Cream Base | Q. S. |
|
| 29 |
Povidone Iodine Ointment USP
5% w/w (For Export) |
Each Composition: Contains:
| Povidone Iodine USP | 5% w/w |
| (Available Iodine | 0.5%w/w ) |
| Water Soluble Ointment Base | Q. S. |
|
| 30 |
Clotrimazole Cream BP 2% w/w
(For Export) |
Each Composition: Contains:
| Clotrimazole BP | 2% w/w |
| Cream Base | Q. S. |
|
| 31 |
Miconazole Cream BP 2% w/w
(For Export) |
Each Composition: Contains:
| Miconazole Nitrate BP | 2% w/w |
| Cream Base | Q. S. |
|
| 32 |
Clotrimazole Cream BP 1% w/w
(For Export) |
Each Composition: Contains:
| Clotrimazole BP | 1% w/w |
| Cream Base | Q. S. |
|
| 33 |
Diclofenac Gel BP 1% w/w
(For Export) |
Each Composition: Contains:
| Diclofenac Diethylamine BP | 1.16 % w/w |
| Equivalent to Diclofenac Sodium | 1% w/w |
| Aqueous Gel Base | Q. S. |
|
| 34 |
Povidone Iodine and
Ornidazole Ointment
(For Export) |
Each Composition: Contains:
| Povidone Iodine USP | 5% w/w |
| (Available iodine | 0.5% w/w) |
| Ornidazole IP | 1% w/w |
| Water soluble ointment base | Q. S. |
|
| 35 |
Povidone-Iodine and
Metronidazole Ointment
(For Export) |
Each Composition: Contains:
| Povidone Iodine USP | 5% w/w |
| (Available iodine | 0.5% w/w) |
| Metronidazole BP | 1% w/w |
| Ointment base | Q. S. |
|
| 36 |
Nitrofurazone and
Chlorocresol Cream
(For Export) |
Each Composition: Contains:
| Nitrofurazone USP | 0.2 % w/w |
| Chlorocresol USP | 0.1 % w/w |
| Cream base | Q. S. |
|
| 37 |
Povidone Iodine Ointment USP
10 % w/w (For Export) |
Each Composition: Contains:
| Povidone Iodine USP | 10 % w/w |
| awailable Iodine | 1.0% w/w |
| Water Soluble Ointment Base | Q. S. |
|
| 38 |
Povidone Iodine Ointment USP
10 % w/w (For Export) |
Each Composition: Contains:
| Povidone Iodine USP | 10 % w/w |
| awailable Iodine | 1.0% w/w |
| Water Soluble Ointment Base | Q. S. |
|
| 39 |
Aciclovir Cream B.P.
(For Export) |
Each Composition: Contains:
| Aciclovir BP | 5.000% w/w |
| Cream Base | Q. S. |
|
| 40 |
Beclomethasone Cream BP
0.025 % w/w (For Export) |
Each Composition: Contains:
| Beclomethasone Dipropionate BP | 0.025 % w/w |
| Cream Base | Q. S. |
|
| 41 |
Beclometasone with
Clotrimazole Cream
(For Export) |
Composition:
| Clotrimazole BP | 1.000 % w/w |
| Beclomethasone Dipropionate BP | 0.025% w/w |
| Cream Base | Q. S. |
|
| 42 |
Beclometasone with
Neomycin Cream
(For Export) |
Composition:
| Beclometasone Dipropionate BP | 0.025% w/w |
| Neomycin Sulfate USP | 0.500% w/w |
| Eq. To Neomycin Base | 0.350% w/w |
| Cream Base | Q. S. |
|
| 43 |
Beclometasone with
Salicylic Acid Cream
(For Export) |
Composition:
| Beclometasone Dipropionate BP | 0.025% w/w |
| Salicylic Acid BP | 3.000% w/w |
| Cream Base | Q. S. |
|
| 44 |
Beclometasone, Gentamicin &
Clotrimazole Cream
(For Export) |
Composition:
| Beclometasone Dipropionate BP | 0.025% w/w |
| Gentamicin Sulfate BP Eq. To. Gentamicin | 0.100% w/w |
| Clotrimazole BP | 1.000% w/w |
| Cream Base | Q. S. |
|
| 45 |
Betamethasone Diporpionate
Cream USP 0.050% w/w
(For Export) |
Composition:
| Betamethasone Dipropionate USP
Eq. To Betamethasone | 0.050% w/w |
| Cream Base | Q. S. |
|
| 46 |
Betamethasone Valerate
Ointment BP 0.12 % w/w
(For Export) |
Composition:
| Betamethasone Valerate BP | 0.120% w/w |
| Ointment Base | Q. S. |
|
| 47 |
Betamethasone Valerate
Ointment BP 0.025% w/w
(For Export) |
Composition:
| Betamethasone Valerate BP | 0.025% w/w |
| Ointment Base | Q. S. |
|
| 48 |
Betamethasone Valerate
Cream BP 0.1 % w/w
(For Export) |
Each Composition:Contains:
| Betamethasone Valerate BP | 0.100% w/w |
| Chlorocresol BP (As preservative) | 0.1% w/w |
| Cream Base | Q. S. |
|
| 49 |
Betamethasone with
Salicylic Acid Ointment
(For Export) |
Composition:
| Betamethasone Dipropionate BP Eq. to Betamethasone | 0.050% w/w |
| Salicylic Acid BP | 3.000% w/w |
| Ointment Base | Q. S. |
|
| 50 |
Clindamycin Phosphate &
Tretinoin gel
(For Export) |
Each Composition Contains:
| Clindamycin Phosphate BP eq. to Clindamycin | 1.000% w/w |
| Tretinoin BP | 0.025% w/w |
| Gel Base | Q. S. |
|
| 51 |
Clindamycin Phosphate Gel
USP 1 % w/w
(For Export) |
Each Composition Contains:
| Clindamycin Phosphate BP Eq. To Clindamycin | 1.000% w/w |
| Gel Base | Q. S. |
|
| 52 |
Clobetasol Cream BP
0.05 % w/w
(For Export) |
Each Composition Contains:
| Clobetasol Propionate BP | 0.5 % w/w |
| Cream Base | Q. S. |
|
| 53 |
Beclometasone Dipropionate,
Gentamicin, Tolnaftate &
Iodochlorhydroxyquinoline
Cream (For Export) |
Each Composition Contains:
| Beclometasone Dipropionate BP | 0.025% w/w |
| Gentamicin (as Sulfate) BP | 0.100 % w/w |
| Iodochlorhydroxyquinoline BP | 1.000% w/w |
| Tolnaftate BP | 1.000% w/w |
| Chlorocresol BP (as preservative) | 0.100 % w/w |
| Cream Base | Q. S. |
|
| 54 |
Clobetasol with
Miconazole Cream
(For Export) |
Each Composition Contains:
| Clobetasol Propionate BP | 0.050% w/w |
| Miconazole Nitrate BP | 2.000% w/w |
| Cream Base | Q. S. |
|
| 55 |
Clobetasol, Gentamicin &
Miconazole Cream
(For Export) |
Each Composition Contains:
| Clobetasol Propionate BP | 0.050% w/w |
| Gentamicin Sulfate BP Eq. To Gentamicin | 0.100% w/w |
| Miconazole Nitrate BP | 2.000% w/w |
| Cream Base | Q. S. |
|
| 56 |
Clobetasol, Gentamicin &
Miconazole Cream
(For Export) |
Each Composition Contains:
| Clobetasol Propionate BP | 0.050% w/w |
| Gentamicin Sulfate BP Eq. To Gentamicin | 0.200% w/w |
| Miconazole Nitrate BP | 2.000% w/w |
| Cream Base | Q. S. |
|
| 57 |
Clobetasol, Gentamicin with
Clotrimazole & Miconazole
Cream (For Export) |
Each Composition Contains:
| Clobetasol Propionate BP | 0.050% w/w |
| Gentamicin Sulfate BP Eq. To Gentamicin | 0.100% w/w |
| Miconazole Nitrate BP | 2.000% w/w |
| Clotrimazole BP | 1.000% w/w |
| Cream Base | Q. S. |
|
| 58 |
Fluocinolone ointment BP
0.025% w/w (For Export) |
Each Composition Contains:
| Fluocinolone Acetonide BP | 0.025 % |
| Ointment Base | Q. S. |
|
| 59 |
Fluocinolone with Neomycin &
Miconazole Cream
(For Export) |
Each Composition Contains:
| Fluocinolone Acetonide BP | 0.100% w/w |
| Neomycin Sulfate USP | 0.500% w/w |
| Miconazole Nitrate BP | 2.000% w/w |
| Cream Base | Q. S. |
|
| 60 |
Fluocinolone, Gentamicin &
Miconazole Cream
(For Export) |
Each Composition Contains:
| Fluocinolone Acetonide BP | 0.010% w/w |
| Gentamicin (as Gentamicin Sulfate BP) | 0.100% w/w |
| Miconazole Nitrate BP | 2.000% w/w |
| Cream Base | Q. S. |
|
| 61 |
Hydrocortisone Acetate
Cream BP 0.5 % w/w
(For Export) |
Each Composition Contains:
| Hydrocortisone Acetate BP | 0.500% w/w |
| Cream Base | Q. S. |
|
| 62 |
Hydroquinone, Tretinoin &
Mometasone Fuorate Gel
(For Export) |
Each Composition Contains:
| Hydroquinone USP | 2.000% w/w |
| Tretinoin USP | 0.025% w/w |
| Mometasone Furoate BP | 0.100% w/w |
| Gel Base | Q. S. |
|
| 63 |
Miconazole with Fluocinolone
Acetonide Cream
(For Export) |
Each Composition Contains:
| Fluocinolone Acetonide BP | 0.025% w/w |
| Miconazole Nitrate BP | 2.000% w/w |
| Cream Base | Q. S. |
|
| 64 |
Miconazole with Fluocinolone
Acetonide Cream
(For Export) |
Each Composition Contains:
| Fluocinolone Acetonide BP | 0.01% w/w |
| Miconazole Nitrate BP | 2.000% w/w |
| Cream Base | Q. S. |
|
| 65 |
Mometasone Fuorate Cream
USP 0.1 % w/w
(For Export) |
Each Composition Contains:
| Mometasone Furoate USP | 0.100% w/w |
| Cream Base | Q. S. |
|
| 66 |
Mometasone Furoate and
Fusidic Acid Cream
(For Export) |
Each Composition Contains:
| Mometasone Furoate BP | 0.1 %w/w |
| Fusidic Acid BP | 2 % w/w |
| Cream Base | Q. S. |
|
| 67 |
Mometasone Furoate and
Fusidic Acid Ointment
(For Export) |
Each Composition Contains:
| Mometasone Furoate BP | 0.1 %w/w |
| Fusidic Acid BP | 2 % w/w |
| Ointment Base | Q. S. |
|
| 68 |
Mupirocin Ointment BP
2% w/w (For Export) |
Each Composition Contains:
| Mupirocin BP | 2 % w/w |
| Ointment Base | Q. S. |
|
| 69 |
Nadifloxacin and
Mometasone Furoate Cream
(For Export) |
Each gm Contains:
| Nadifloxacin | 10 mg |
| Mometsone Furoate BP | 1 mg |
| Cream Base | Q. S. |
|
| 70 |
Nadifloxacin Gel 1% w/w
(For Export) |
Each Composition Contains:
| Nadifloxacin | 1% w/w |
| Gel Base | Q. S. |
|
| 71 |
Nadifloxacin,
Miconazole Nitrate and
Mometasone Furoate Cream
(For Export) |
Each Composition Contains:
| Nadifloxacin | 1% w/w |
| Miconazole Nitrate BP | 2% w/w |
| Mometasone Furoate BP | 0.1% w/w |
| Cream Base | Q. S. |
|
| 72 |
Neomycin Sulfate Ointment
USP 0.5% w/w
(For Export) |
Each Composition Contains:
| Neomycin Sulfate USP | 0.5 % w/w |
| Eq. To Neomycin Base | 0.35% w/w |
| Cream Base | Q. S. |
|
| 73 |
Ofloxacin Ornidazole,
Itraconazole & Clobetasol
Propionate cream
(For Export) |
Each Composition Contains:
| Ofloxacin BP | 0.075 % w/w |
| Ornidazole BP | 2.0 % w/w |
| Itraconazole USP | 1% w/w |
| Clobetasol Propionate BP | 0.05% w/w |
| Methyl Paraben BP (As preservative) | 0.2% w/w |
| Propylparaben BP (As preservative) | 0.2% w/w |
| Cream Base | Q. S. |
|
| 74 |
Sertaconazole Nitrate Cream
2 % w/w (For Export) |
Each Composition Contains:
| Sertaconazole Nitrate | BP 2% w/w |
| Cream Base | Q. S. |
|
| 75 |
Ofloxacin, Ornidazole,
Terbinafine & Clobetasol
Propionate cream
(For Export) |
Each Composition Contains:
| Ofloxacin BP | 0.075 % w/w |
| Ornidazole BP | 2.0 % w/w |
| Terbinafine Hydrochloride BP | 1% w/w |
| Clobetasol Propionate BP | 0.05% w/w |
| Methyl Paraben BP (As preservative) | 0.2% w/w |
| Propylparaben BP (As preservative) | 0.2% w/w |
| Cream Base | Q. S. |
|
| 76 |
Polymixin B Sulfate,
Bacitracin Zinc &
Neomycin Sulfate Cream
(For Export) |
Each gm Contains:
| Polymixin B Sulfate | 5000 IU |
| Bacitracin Zinc BP | 400 IU |
| Neomycin Sulfate USP | 3400 IU |
| Cream Base | Q. S. |
|
| 77 |
Terbinafine Hydrochloride
Cream 1% w/w
(For Export) |
Each Composition Contains:
| Terbinafine Hydrochloride BP | 1% w/w |
| Benzyl Alcohol BP (As preservative) | 1% w/w |
| Cream Base | Q. S. |
|
| 78 |
Tetracycline Skin Ointment
1 % w/w (For Export) |
Each Composition Contains:
| Tetracycline Hydrochloride BP | 1 % w/w |
| Ointment Base | Q. S. |
|
| 79 |
Beclometasone with
Clioquinol Cream
(For Export) |
Each Composition Contains:
| Beclometasone Dipropionate BP | 0.025% w/w |
| Iodochlorhydroxyquinoline (Clioquinol) BP | 3.000% w/w |
| Cream Base | Q. S. |
|
| 80 |
Clobetasol Propionate,
Gentamicin Sulfate, Tolnaftate,
Iodochlor hydroxyquinoline &
Clotrimazole Cream
(For Export) |
Each Composition Contains:
| Clobetasol Propionate BP | 0.05% w/w |
| Gentamicin Sulfate BP Eq. to Gentamicin | 0.1% w/w |
| Tolnaftate BP | 1.0% w/w |
| Iodochlorhydroxyquinoline BP | 1.0% w/w |
| Clotrimazole BP | 1.0% w/w |
| Cream Base | Q. S. |
|
| 81 |
Clobetasol Propionate,
Neomycin Sulfate and
Miconazole Nitrate &
Zinc Sulfate cream
(For Export) |
Each Composition Contains:
| Clobetasol Propionate BP | 0.05% w/w |
| Neomycin Sulfate USP Eq. To Neomycin | 0.5% w/w |
| Miconazole Nitrate BP | 2% w/w |
| Zinc Sulfate Monohydrate BP | 0.1% w/w |
| Cream Base | Q. S. |
|
| 82 |
Hydrocortisone Acetate
Cream BP 1%w/w
(For Export) |
Each Composition Contains:
| Hydrocortisone Acetate BP | 1.00% w/w |
| Cream Base | Q. S. |
|
| 83 |
Clobetasol Propionate,
Neomycin Sulfate and
Miconazole Nitrate cream
(For Export) |
Each Composition Contains:
| Clobetasol Propionate BP | 0.05 w/w |
| Neomycin Sulfate USP Eq. To Neomycin | 0.5 w/w |
| Miconazole Nitrate BP | 2.00 w/w |
| Chlorocresol BP (As preservative) | 0.1% w/w/td> |
| Cream Base | Q. S. |
|
| 84 |
Beclomethasone Dipropionate,
Neomycin Sulfate and
Clotrimazole Cream
(For Export) |
Each Composition Contains:
| Beclomethasone Dipropionate USP | 0.025% w/w |
| Neomycin Sulfate USP | 0.5% w/w |
| Eq. to Neomycin Base | 0.35% w/w |
| Clotrimazole BP | 1.0% w/w |
| Cream Base | Q. S. |
|
| 85 |
Beclomethasone Dipropionate,
Neomycin Sulfate and
Miconazole Nitrate Cream
(For Export) |
Each Composition Contains:
| Beclomethasone Dipropionate USP | 0.025% w/w |
| Neomycin Sulfate USP | 0.5% w/w |
| Eq. to Neomycin Base | 0.35% w/w |
| Miconazole Nitrate | 2.0% w/w |
| Cream Base | Q. S. |
|
| 86 |
Luliconazole Cream 1% w/w
(For Export) |
Each Composition Contains:
| Luliconazole | 1% w/w |
| Cream Base | Q. S. |
|
